Aspira women's health announces closing of $1.9 million private placement equity financing

Austin, texas, july 09, 2024 (globe newswire) -- aspira women's health inc. (“aspira” or the “company”) (nasdaq: awh), a bio-analytical based women's health company focused on the development of gynecologic disease diagnostic tools, today announced that it has closed its previously announced private placement for the issuance and sale of shares of the company's common stock and accompanying warrants to purchase an equal number of shares for gross proceeds of approximately $1.9 million. aspira has the potential to receive additional gross proceeds of up to $2.8 million, before deducting offering expenses, upon the full cash exercise of warrants issued in the private placement.
AWH Ratings Summary
AWH Quant Ranking